The Association Between Metabolic Derangement and Wound Complications in Elective Plastic Surgery.


Journal

The Journal of surgical research
ISSN: 1095-8673
Titre abrégé: J Surg Res
Pays: United States
ID NLM: 0376340

Informations de publication

Date de publication:
10 2022
Historique:
received: 02 10 2021
revised: 17 02 2022
accepted: 19 03 2022
pubmed: 20 5 2022
medline: 27 7 2022
entrez: 19 5 2022
Statut: ppublish

Résumé

The incidence of metabolically unhealthy obesity is rising nationally. In this study, we compare wound and overall complications between metabolically unhealthy obese and healthy patients undergoing elective plastic surgery and model how operative time influences a complication risk. Patients undergoing elective breast and body plastic surgery procedures in the 2009-2019 National Surgical Quality Improvement Program (NSQIP) dataset were identified. Complications were compared between metabolically unhealthy obese (body mass index [BMI] > 30 with diabetes and/or hypertension) versus metabolically healthy obese patients (BMI > 30 without diabetes or hypertension). Logistic regression was used to model the probability of wound complications across operative times stratified by metabolic status. Of 139,352 patients, 13.4% (n = 18,663) had metabolically unhealthy obesity and 23.8% (n = 33,135) had metabolically healthy obesity. Compared to metabolically healthy patients, metabolically unhealthy patients had higher incidence of wound complications (6.9% versus 5.6%; P < 0.001) and adverse events (12.4% versus 9.6%; P < 0.001), in addition to higher 30-d readmission, returns to the operating room, and length of stay (all P < 0.001). After adjustment, BMI (Odds ratio [OR] 7.86), hypertension (OR 1.15), and diabetes (OR 1.25) were independent risk factors for wound complications (all P < 0.001). Among metabolically unhealthy patients, the operative time was log-linear with a wound complication risk (OR 1.21; P < 0.001). Diabetes and hypertension are additive risk factors with obesity for wound complications in elective plastic surgery. Among patients with metabolically unhealthy obesity, a risk of wound complications increases logarithmically with operative time. This distinction with regard to metabolic state might explain the unclear impact of obesity on surgical outcomes within existing surgical literature.

Identifiants

pubmed: 35588573
pii: S0022-4804(22)00165-2
doi: 10.1016/j.jss.2022.03.017
pmc: PMC9329200
mid: NIHMS1809490
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-48

Subventions

Organisme : NCI NIH HHS
ID : R01 CA222170
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA243004
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Références

J Am Coll Surg. 2013 Oct;217(4):656-64
pubmed: 23891077
Aesthet Surg J. 2017 Mar 1;37(3):308-315
pubmed: 28207040
Plast Reconstr Surg. 2019 Jul;144(1):1e-8e
pubmed: 31246793
Aesthet Surg J. 2017 May 1;37(5):515-527
pubmed: 28333172
J Reconstr Microsurg. 2018 Jun;34(5):363-375
pubmed: 29510420
Aesthet Surg J. 2014 May 1;34(4):614-22
pubmed: 24696297
Plast Reconstr Surg. 2014 Apr;133(4):559e-566e
pubmed: 24675208
Aesthetic Plast Surg. 2020 Oct;44(5):1615-1624
pubmed: 32342171
Ann Surg. 2018 May;267(5):858-862
pubmed: 28549013
Wound Repair Regen. 2012 Jul-Aug;20(4):512-22
pubmed: 22672117
Plast Reconstr Surg. 2020 Mar;145(3):619-627
pubmed: 32097293
J Plast Reconstr Aesthet Surg. 2013 Feb;66(2):231-8
pubmed: 23040202
Circulation. 2004 Sep 7;110(10):1245-50
pubmed: 15326067
Plast Reconstr Surg. 2014 Jan;133(1):173-180
pubmed: 24105090
Nat Rev Genet. 2008 Nov;9(11):819-30
pubmed: 18852695
Aesthet Surg J. 2015 Nov;35(8):999-1006
pubmed: 26163312
Plast Reconstr Surg. 2015 Dec;136(6):1312-1323
pubmed: 26291701
Metabolism. 2019 Apr;93:18-24
pubmed: 30639450
Am J Surg. 2020 Aug;220(2):448-453
pubmed: 31879020
Ann Plast Surg. 2016 May;76(5):576-84
pubmed: 25536199
Surgery. 2012 Aug;152(2):218-26
pubmed: 22828143
Plast Reconstr Surg. 2015 Nov;136(5):968-977
pubmed: 26505701
Aesthet Surg J. 2016 Jun;36(6):718-29
pubmed: 26895958
Plast Reconstr Surg. 2018 Aug;142(2):355-362
pubmed: 30045177
J Surg Res. 2020 Jan;245:544-551
pubmed: 31470335
Nature. 2006 Dec 14;444(7121):881-7
pubmed: 17167477
Aesthet Surg J. 2016 Jul;36(7):792-803
pubmed: 27217588
J Plast Surg Hand Surg. 2020 Jul 09;:1-9
pubmed: 32643518
Plast Reconstr Surg. 2011 Jun;127(6):2206-2213
pubmed: 21617454
Head Neck. 2021 Apr;43(4):1271-1279
pubmed: 33368806
Metabolism. 2019 Mar;92:51-60
pubmed: 30458177
J Plast Reconstr Aesthet Surg. 2015 Apr;68(4):531-9
pubmed: 25557724
Plast Reconstr Surg. 2019 Oct;144(4):847-853
pubmed: 31568289
Prev Chronic Dis. 2017 Mar 16;14:E24
pubmed: 28301314
Plast Reconstr Surg. 2015 Nov;136(5):597e-606e
pubmed: 26505716
Plast Reconstr Surg. 2016 Jan;137(1):351-360
pubmed: 26371388
J Plast Surg Hand Surg. 2014 Oct;48(5):334-9
pubmed: 24506446
Obes Surg. 2020 Jan;30(1):319-326
pubmed: 31625057
J Surg Res. 2014 Dec;192(2):670-7
pubmed: 24972736
Foot Ankle Spec. 2020 Apr;13(2):93-103
pubmed: 30712372
J Gastrointest Surg. 2019 Apr;23(4):739-744
pubmed: 30430431
Dis Colon Rectum. 2019 Jul;62(7):849-858
pubmed: 31188186
Spine (Phila Pa 1976). 2018 May 1;43(9):661-666
pubmed: 28858182
Am Surg. 2021 Jul;87(7):1155-1162
pubmed: 33345564
Lancet. 2005 Apr 16-22;365(9468):1415-28
pubmed: 15836891
Plast Reconstr Surg. 2018 Sep;142(3 Suppl):21S-29S
pubmed: 30138261

Auteurs

Amanda R Sergesketter (AR)

Division of Plastic, Oral, and Maxillofacial Surgery, Duke University, Durham, North Carolina.

Yisong Geng (Y)

Calc LLC, Wilton, Connecticut.

Ronnie L Shammas (RL)

Division of Plastic, Oral, and Maxillofacial Surgery, Duke University, Durham, North Carolina.

Gerald V Denis (GV)

Section of Hematology/Oncology, Boston University School of Medicine, Boston, Massachusetts.

Robin Bachelder (R)

Division of Plastic, Oral, and Maxillofacial Surgery, Duke University, Durham, North Carolina.

Scott T Hollenbeck (ST)

Division of Plastic, Oral, and Maxillofacial Surgery, Duke University, Durham, North Carolina. Electronic address: scott.hollenbeck@duke.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH